Literature DB >> 19197558

Successful treatment of mucous membrane pemphigoid with the anti-CD-20 antibody rituximab.

Tamara Schumann, Enno Schmidt, Nina Booken, Sergij Goerdt, Matthias Goebeler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197558     DOI: 10.2340/00015555-0560

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  8 in total

1.  Rituximab for autoimmune blistering diseases: recent studies, new insights.

Authors:  L Lunardon; A S Payne
Journal:  G Ital Dermatol Venereol       Date:  2012-06       Impact factor: 2.011

Review 2.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

Review 3.  Autoimmunity at the ocular surface: pathogenesis and regulation.

Authors:  M E Stern; C S Schaumburg; R Dana; M Calonge; J Y Niederkorn; S C Pflugfelder
Journal:  Mucosal Immunol       Date:  2010-05-19       Impact factor: 7.313

Review 4.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

5.  Monoclonal anti-CD20 Antibody Therapy in Cicatrical Pemphigoid with Oral and Hypopharyngeal Involvement and Related Conditions.

Authors:  Uwe Wollina; Friedemann Pabst; Heidrun Kuss; Michaela Tilp; Juliane Runge
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

Review 6.  Mucous membrane pemphigoid.

Authors:  Hong-Hui Xu; Victoria P Werth; Ernesta Parisi; Thomas P Sollecito
Journal:  Dent Clin North Am       Date:  2013-08-15

7.  Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study.

Authors:  Caiyun You; Neerav Lamba; Andres F Lasave; Lina Ma; Mikhail Hernandez Diaz; C Stephen Foster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-03       Impact factor: 3.535

Review 8.  Off-Label Uses of Rituximab in Dermatology.

Authors:  Connor Cole; Kyle T Amber
Journal:  Curr Dermatol Rep       Date:  2022-10-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.